EUCTR2014-003512-37-BEActive, not recruitingPhase 1
Study of the (intravenously injected) ICG (Indocyanine Green) imaging of tumoral implants in patients with peritoneal carcinomatosis from colorectal origin.
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Jules Bordet Institute
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •- Patients (either newly diagnosed, or relapsing) with peritoneal carcinomatosis from colorectal carcinoma who are candidate for open” surgery.
- •- Informed consent form signed.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •- Age less than18 years old.
- •- Inability to give informed consent.
- •- History of allergy or hypersensitivity against the investigational product (its active substance or ingredients), to iodine or to shellfish.
- •- Apparent hyperthyroidism, autonomous thyroid adenoma, unifocal, multifocal or disseminated autonomies of the thyroid gland.
- •- Documented coronary disease.
- •- Advanced renal impairment (creatinine > 1,5mg/dl).
- •- During the 2 weeks before the enrolment, concurrent medication which reduces or increases the extinction of ICG (i.e. anticonvulsants, haloperidol and heparin).
- •- Pregnancy, breastfeeding
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Study of the possibility to visualize and define margins of breast tumours with a near-infrared camera thanks to the IV injection of Indocyanine Green, a fluorescent molecule.imaging of tumours and their margins after intravenous injection of Indocyanine Green to breast cancer patientsEUCTR2013-004496-12-BEInstitut Jules Bordet
Recruiting
Unknown
Dose Comparison Study of Intravenous ICG Dose in Lung Malignant Tumor Localization Method Using Fluorescence Spectroscopy SystePrimary lung cancer(or suspicious), or metastatic lung tumor (or suspicious)malignant lung tumorJPRN-jRCTs011230037Kato Tatsuya60
Completed
Not Applicable
The No IntraCranial Haemorrhage (NOICH) StudyFoetal or neonatal alloimmune thrombocytopeniaPregnancy and ChildbirthOther perinatal haematological disordersISRCTN29462550eiden University Medical Centre (LUMC) (Netherlands)212
Active, not recruiting
Phase 1
Intravenous immunoglobulin (IVIG) treatment in children with PANS: a clinical trial in South-western SwedeEUCTR2019-004758-27-SEGillberg Neuropsychiatry Centre10
Completed
Not Applicable
The efficacy of intravenous immunoglobulin(IVIG) for the maintenance phase of treatment for children with acute lymphoblastic leukemia(ALL)Acute lymphoblastic leukemiaJPRN-UMIN000015179agoya University Graduate School of Medicine30